Numerous researches have been reported RAFT-generated thermo-responsive copolymers of PNIPAAm acted as drug carriers. For example, Bohec
et al. fabricated a well-defined Tpy-PDMA-
b-P(NIPAAm-
co-VDM) hydrophilic block copolymer by sequential RAFT polymerization with terpyridine (Tpy-CTA) as RAFT agent (
Fig. 9) [
109]. A metallic bis-terpyridine complex (Fe(Tpy-PDMA-
b-P(NIPAAm-
co-VDM))
2]
2+) could be formed by the introduction of Fe
2+ into a concentrated solution of Tpy-PDMA-
b-P(NIPAAm-
co-VDM) (8% w/v). With the increasing of temperature, a hydrogel could be formed by the self-assembly of the thermo-responsive P(NIPAAm-
co-VDM) blocks. Such sol-gel thermo-reversible transition favor Tpy-PDMA-
b-P(NIPAAm-
co-VDM) micelles the potential as thermo-responsive drug release systems. Zeng
et al. synthesized poly(
N-isopropylacrylamide)-
g-poly(sulfobetaine methacrylate) hydrogel (GH) by sequential RAFT polymerization with 2-(2-carboxyethylsulfanylthiocarbonyl sulfanyl) propionic acid as RAFT agent [
110]. Compared to traditional PNIPAAm-
co-PSBMA hydrogel (CH), GH performed a faster shrinking rate (losing more than 72% of the water within 15min) owning to a highly porous architecture. The
in vitro test showed that the sustained release of tetracycline hydrochloride from GH could reach 48h, which was much longer than that of CH (only 5h). Tang
et al. synthesized thermo-sensitive di-block copolymer, PNIPAAm-
b-POAG, in which POAG acted as a biocompatible segment,
via sequential RAFT polymerization [
111]. The excellent sol-gel transition performance within a temperature range, covered the physiological conditions, enabled PNIPAAm-
b-POAG micelles to transform into hydrogel immediately after the injection into physiological conditions. Especially, the
in vitro test indicated that such PNIPAAm-
b-POAG hydrogel could realize the sustained release of methylene blue for 120h. Prosperiporta
et al. synthesized copolymers with varying NIAAm, AAm, acrylic acid
N-hydroxysuccinimide (NAS), and (
R)-
α-acryloyloxy-
β,
β-dimethyl-
γ-butyrolactone (DBA) by RAFT polymerization with 2-(dodecylthio-carbonothioylthio)-2-methylpropionic acid as RAFT agent [
112]. After the injection into physiological conditions, poly(NIPAAm-AAm-NAS-DBA) copolymers could undergo a sol-gel transition by the trigger of temperature and work as a scaffold for controlled release of ophthalmic therapeutics. The physical properties and drug release behavior of such scaffold could be precisely modulated by varying monomer ratio and molecular weight of each monomer.